Biobank equipment market seen reaching $6.5 billion by 2030

The biobank equipment market is projected to grow from $4.18 billion in 2025 to $6.5 billion by 2030, driven by personalized medicine, automation, and demand for better sample storage and tracking. North America leads today, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Biobank equipment sits at the center of sample storage, traceability and data quality for clinical research, genomics and personalized medicine. - The market’s projected move to $6.5 billion by 2030 points to sustained demand for automated systems, cryogenic monitoring and cloud-based tracking tools.

What happened: - The Business Research Company released a report on the global biobank equipment market on July 28, 2026. - The report says the market will rise from $4.18 billion in 2025 to $4.58 billion in 2026. - The report projects the market will reach $6.5 billion by 2030. - The company also said the market is growing at a 9.5% CAGR from 2025 to 2026 and is forecast to grow at a 9.2% CAGR through 2030. - The report includes a free sample at Download a free sample of the biobank equipment market report. - The full report is available at View the full biobank equipment market report.

The details: - Biobank equipment covers tools and systems used to collect, process and preserve biological samples under controlled conditions. - The equipment is designed to maintain long-term sample integrity, quality and traceability. - Past growth has been driven by biobanking initiatives, more clinical research, manual sample-handling challenges, the need for reliable traceability and more genomics research. - Future growth is tied to automated and hybrid biobanking technologies, AI and cloud analytics, regenerative medicine research, cell and DNA storage demand, and cryogenic technology advances. - Key trends include AI-powered sample management, IoT-enabled cryogenic monitoring, fully automated biobanking platforms, cloud-based data tracking systems and high-throughput storage solutions. - Personalized medicine is one of the main growth drivers because it depends on biological samples that can support biomarker discovery and patient-specific treatments. - The Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized therapies for rare-disease patients in 2023, up from six in 2022. - North America was the largest biobank equipment market in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests biobanking is shifting from a support function to a core research infrastructure category. - AI, cloud software and automation are becoming as important to the market as cold-storage hardware. - The regional outlook hints that growth is broadening beyond established research hubs as more countries scale clinical and genomics capacity.

What's next: - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspot infographics and updated trend analysis. - The company invited inquiries through its listed sales and media contacts. - The Business Research Company also posted social links on LinkedIn, Facebook and X.